NeoGenomics (NEO) Competitors $5.16 +0.32 (+6.61%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$5.16 0.00 (-0.10%) As of 08/1/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO vs. FA, DLO, ALIT, CLVT, YY, PAGS, DXC, ACVA, RNG, and PAYOShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include First Advantage (FA), DLocal (DLO), Alight (ALIT), Clarivate (CLVT), JOYY (YY), PagSeguro Digital (PAGS), DXC Technology (DXC), ACV Auctions (ACVA), Ringcentral (RNG), and Payoneer Global (PAYO). These companies are all part of the "business services" industry. NeoGenomics vs. Its Competitors First Advantage DLocal Alight Clarivate JOYY PagSeguro Digital DXC Technology ACV Auctions Ringcentral Payoneer Global NeoGenomics (NASDAQ:NEO) and First Advantage (NYSE:FA) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations. Is NEO or FA more profitable? First Advantage has a net margin of 0.65% compared to NeoGenomics' net margin of -15.10%. First Advantage's return on equity of 13.16% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets NeoGenomics-15.10% -2.72% -1.54% First Advantage 0.65%13.16%7.33% Do analysts prefer NEO or FA? NeoGenomics presently has a consensus price target of $12.88, suggesting a potential upside of 149.52%. First Advantage has a consensus price target of $20.25, suggesting a potential upside of 22.95%. Given NeoGenomics' stronger consensus rating and higher probable upside, equities analysts clearly believe NeoGenomics is more favorable than First Advantage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeoGenomics 0 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33First Advantage 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Does the media prefer NEO or FA? In the previous week, NeoGenomics had 37 more articles in the media than First Advantage. MarketBeat recorded 39 mentions for NeoGenomics and 2 mentions for First Advantage. First Advantage's average media sentiment score of 1.84 beat NeoGenomics' score of -0.06 indicating that First Advantage is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 3 Very Positive mention(s) 5 Positive mention(s) 16 Neutral mention(s) 7 Negative mention(s) 2 Very Negative mention(s) Neutral First Advantage 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals have more ownership in NEO or FA? 98.5% of NeoGenomics shares are held by institutional investors. Comparatively, 94.9% of First Advantage shares are held by institutional investors. 2.4% of NeoGenomics shares are held by insiders. Comparatively, 5.3% of First Advantage shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings and valuation, NEO or FA? First Advantage has higher revenue and earnings than NeoGenomics. First Advantage is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeoGenomics$689.19M0.97-$78.73M-$0.81-6.37First Advantage$1.05B2.74$37.29M-$0.91-18.10 Which has more volatility & risk, NEO or FA? NeoGenomics has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, First Advantage has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. SummaryFirst Advantage beats NeoGenomics on 9 of the 16 factors compared between the two stocks. Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$666.56M$2.99B$5.48B$9.53BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-6.3717.7428.8623.83Price / Sales0.97178.71371.4466.13Price / Cash11.0341.9535.4557.96Price / Book0.788.508.265.54Net Income-$78.73M-$55.06M$3.25B$259.28M7 Day Performance-17.97%-3.99%-3.73%-4.67%1 Month Performance-30.27%9.58%4.28%4.38%1 Year Performance-69.95%6.70%25.85%17.90% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics4.1222 of 5 stars$5.16+6.6%$12.88+149.5%-70.5%$666.56M$689.19M-6.372,200Trending NewsAnalyst ForecastFAFirst Advantage1.561 of 5 stars$18.16-1.3%$20.25+11.5%-3.3%$3.15B$1.05B605.335,500Positive NewsDLODLocal2.668 of 5 stars$10.99+1.5%$12.45+13.3%+36.4%$3.14B$745.97M22.431,095News CoverageAnalyst ForecastALITAlight3.902 of 5 stars$5.69-1.2%$9.86+73.2%-30.7%$3.06B$2.33B-40.649,500Upcoming EarningsGap DownCLVTClarivate3.172 of 5 stars$4.28-5.5%$4.83+12.9%-44.1%$2.92B$2.56B-4.4112,000News CoverageEarnings ReportYYJOYY1.4891 of 5 stars$51.07-1.8%$35.00-31.5%+51.9%$2.75B$2.24B15.437,450News CoveragePositive NewsPAGSPagSeguro Digital3.9584 of 5 stars$8.10-0.7%$11.36+40.2%-37.5%$2.67B$18.84B6.648,595News CoverageDXCDXC Technology4.2212 of 5 stars$14.24-0.4%$17.00+19.4%-35.3%$2.58B$12.87B6.75120,000Trending NewsEarnings ReportAnalyst ForecastACVAACV AuctionsN/A$14.45-0.9%N/AN/A$2.47B$637.16M-32.112,900RNGRingcentral4.9433 of 5 stars$27.28+2.2%$33.08+21.2%-29.3%$2.45B$2.40B-62.004,260News CoveragePositive NewsUpcoming EarningsPAYOPayoneer Global4.4041 of 5 stars$6.72-1.3%$9.81+46.0%+11.9%$2.43B$977.72M22.402,407News CoveragePositive NewsUpcoming EarningsGap Down Related Companies and Tools Related Companies First Advantage Alternatives DLocal Alternatives Alight Alternatives Clarivate Alternatives JOYY Alternatives PagSeguro Digital Alternatives DXC Technology Alternatives ACV Auctions Alternatives Ringcentral Alternatives Payoneer Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.